BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
CXCL2
,
T cell receptor signaling pathway
,
Allergy to pollen
,
Intestine
,
Fluoxetine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
RNA polymerase II general transcription initiation factor activity
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
No compounds found
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
GCN4
GCR2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Transcription factors Bas1, Pho2, Gcn4, and Gcr2 knockout in yeast
S. cerevisiae exponential cultures; nitrogen sources shifted between proline and glutamine
S. pombe Zfs1p and Cbf12p double and single null mutants
Profiling oxidative stress in S. cerevisiae by oxidation of transcription factor Swi6p
S. pombe with mutations in MYST and GNAT family acyl transferases
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for RNA polymerase II general transcription initiation factor activity
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
Peri-implantitis and MMP-8
Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia …
A Study of TY-2699a in Patients With Locally Advanced or Metastatic Solid Tumors
Involvement of the Gut Microbiota-brain Cross-talk in the Loss of Eating Control
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ